We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$29.2B
AUM Growth
+$1.4B
(+5%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
23.08%
Holding
3,780
New
179
Increased
1,287
Reduced
1,288
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$43M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$29.1M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$28.4M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$27.3M |
| 5 |
Amazon
AMZN
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$44.4M |
| 2 |
US Bancorp
USB
|
+$24.3M |
| 3 |
STJ
St Jude Medical
STJ
|
+$23.2M |
| 4 |
SE
Spectra Energy Corp Wi
SE
|
+$20.8M |
| 5 |
Vanguard Long-Term Bond ETF
BLV
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.17% |
| 2 | Financials | 11.31% |
| 3 | Healthcare | 10.5% |
| 4 | Technology | 9.1% |
| 5 | Consumer Staples | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
TSMC
TSM
$2.16T
| $23.7M | 0.08% |
720,187
-32,311
| -4% | -$1.01M |
|
202
Novartis
NVS
$297B
| $23.3M | 0.08% |
349,758
-9,286
| -3% | -$619K |
|
|
PXD
203
DELISTED
Pioneer Natural Resource Co.
PXD
| $22.9M | 0.08% |
122,809
-3,273
| -3% | -$607K |
|
204
American Electric Power
AEP
$73.4B
| $22.8M | 0.08% |
340,261
-5,950
| -2% | -$385K |
|
205
Cognizant
CTSH
$20.3B
| $22.8M | 0.08% |
383,391
-20,417
| -5% | -$1.17M |
|
206
Align Technology
ALGN
$12B
| $22.6M | 0.08% |
197,025
-11,639
| -6% | -$1.18M |
|
|
CAJ
207
DELISTED
Canon, Inc.
CAJ
| $22.4M | 0.08% |
716,741
+21,880
| +3% | +$649K |
|
208
Canadian Natural Resources
CNQ
$98B
| $22M | 0.08% |
1,367,450
+507,739
| +59% | +$7.68M |
|
209
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $21.8M | 0.07% |
260,641
+104,562
| +67% | +$8.71M |
|
210
International Paper
IP
$20.1B
| $21.5M | 0.07% |
446,083
-11,090
| -2% | -$556K |
|
211
Vanguard S&P 500 ETF
VOO
$967B
| $21.3M | 0.07% |
98,445
+12,524
| +15% | +$2.67M |
|
212
State Street
STT
$50.6B
| $21.3M | 0.07% |
267,126
+5,297
| +2% | +$420K |
|
213
Baxter International
BAX
$11.2B
| $21.2M | 0.07% |
408,750
+3,102
| +0.8% | +$153K |
|
214
Danaher
DHR
$135B
| $21.1M | 0.07% |
277,949
+159
| +0.1% | +$11.8K |
|
215
O'Reilly Automotive
ORLY
$71.4B
| $21.1M | 0.07% |
1,171,470
+98,670
| +9% | +$1.78M |
|
216
Intuit
INTU
$77B
| $21.1M | 0.07% |
181,575
-33,136
| -15% | -$3.97M |
|
217
iShares MSCI USA Quality Factor ETF
QUAL
$45.6B
| $20.8M | 0.07% |
285,624
-8,954
| -3% | -$642K |
|
218
Edwards Lifesciences
EW
$48.3B
| $20.4M | 0.07% |
649,392
+268,818
| +71% | +$8.42M |
|
219
TransDigm Group
TDG
$67.9B
| $20.3M | 0.07% |
92,346
+87,657
| +1,869% | +$20.9M |
|
220
Helmerich & Payne
HP
$3.5B
| $20.2M | 0.07% |
303,054
+76,291
| +34% | +$5.43M |
|
221
SAP
SAP
$171B
| $20.1M | 0.07% |
204,580
+5,182
| +3% | +$481K |
|
222
Stryker
SYK
$122B
| $20M | 0.07% |
152,172
-5,052
| -3% | -$638K |
|
223
Zimmer Biomet
ZBH
$17.3B
| $20M | 0.07% |
168,962
-10,254
| -6% | -$1.16M |
|
224
Hasbro
HAS
$12.4B
| $20M | 0.07% |
200,568
-5,717
| -3% | -$529K |
|
225
Amphenol
APH
$194B
| $19.9M | 0.07% |
1,115,724
-32,880
| -3% | -$569K |
|
Similar funds
US Bancorp's Q1 2017 Portfolio in Review
As of Q1 2017, US Bancorp held 3,780 positions worth $29.2B, up 5% from $27.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q1 2017 filing shows 179 new, 1,287 increased, 1,288 reduced and 176 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M. The largest sale was Berkshire Hathaway Class A, an estimated $44.4M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- US Bancorp's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M.
- US Bancorp added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $43M increase.
- US Bancorp's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $44.4M.
- US Bancorp fully exited St Jude Medical in Q1 2017, selling an estimated $23.2M.
- US Bancorp's ten largest holdings make up 23% of its $29.2B portfolio in Q1 2017.
- US Bancorp opened 179 new positions and closed 176 in Q1 2017.
- US Bancorp's portfolio value rose 5% quarter-over-quarter to $29.2B.
Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.